Serologic profiling of D variants in donor routine: unveiling the impact on false-negative results and alloimmunization.


Journal

Immunohematology
ISSN: 0894-203X
Titre abrégé: Immunohematology
Pays: United States
ID NLM: 8806387

Informations de publication

Date de publication:
01 Jun 2024
Historique:
medline: 24 6 2024
pubmed: 24 6 2024
entrez: 24 6 2024
Statut: epublish

Résumé

The high number of D variants can lead to the unnecessary use of Rh immune globulin, overuse of D- RBC units, and anti-D allommunization. D variant prevalence varies among ethnic groups, and knowledge of the main variants present in a specific population, their behavior in serologic tests, and their impact on clinical practice is crucial to define the best serologic tests for routine use. The present study aimed to explore the serologic profile of D variants and to determine which variants are most associated with false-negative D typing results and alloimmunization. Donor samples were selected in two study periods. During the first period, D typing was performed on a semi-automated instrument in microplates, and weak D tests were conducted in tube or gel tests. In the second period, D typing was carried out using an automated instrument with microplates, and weak D tests were performed in solid phase. Samples from patients typed as D+ with anti-D were also selected. All samples were characterized by molecular testing. A total of 37

Identifiants

pubmed: 38910444
pii: immunohematology-2024-007
doi: 10.2478/immunohematology-2024-007
doi:

Substances chimiques

Rh-Hr Blood-Group System 0
Isoantibodies 0
Rho(D) Immune Globulin 0
Rho(D) antigen 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

47-53

Informations de copyright

© 2024 Carine P. Arnoni et al., published by Sciendo.

Références

Flegel WA. Molecular genetics of RH and its clinical application. Transfus Clin Biol 2006;13:4–12.
Avent ND, Reid ME. The Rh blood group system: a review. Blood 2000;95:375–87.
Sandler SG, Flegel WA, Westhoff CM, et al. It’s time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group. Transfusion 2015;55:680–9.
International Society of Blood Transfusion. Red cell immunogenetics and blood group terminology. 2023. Available from http://www.isbtweb.org/working-parties/red-cell-immunogenetics-and-blood-group-terminology/.
Stegmann TC, Veldhuisen B, Bijman R, et al. Frequency and characterization of known and novel RHD variant alleles in 37,782 Dutch D-negative pregnant women. Br J Haematol 2016;173:469–79.
Flegel WA, Denomme GA, Queenan JT, et al. It’s time to phase out “serologic weak D phenotype” and resolve D types with RHD genotyping including weak D type 4. Transfusion 2020;60:855–9.
Arnoni CP, Latini FR, Muniz JG, et al. How do we identify RHD variants using a practical molecular approach? Transfusion 2014;54:962–9.
Fichou Y, Le Marechal C, Bryckaert L, et al. A convenient qualitative and quantitative method to investigate RHD-RHCE hybrid genes. Transfusion 2013;53:2974–82.
Arnoni CP, Muniz JG, de Paula Vendrame TA, et al. Identification of four novel RHD alleles with altered expression of D in Brazilians. Transfusion 2016;56: 1475-6.
Costa S, Martin F, Chiba A, Langhi D Jr, Chiattone C, Bordin J. RHD alleles and D antigen density among serologically D− C+ Brazilian blood donors. Transfus Med 2014;24:60–1.
Mota M, Dezan M, Valgueiro M, Sakashita A, Kutner J, Castilho L. RHD allelic identification among D— Brazilian blood donors as a routine test using pools of DNA. J Clin Lab Anal 2012;26:104–8.
Wagner FF, Gassner C, Muller TH, Schonitzer D, Schunter F, Flegel WA. Molecular basis of weak D phenotypes. Blood 1999;93:385–93.
Wagner FF, Frohmajer A, Flegel WA. RHD positive haplotypes in D negative Europeans. BMC Genet 2001;2:10.
Wagner FF, Flegel WA. The rhesus site. Transfus Med Hemother 2014;41:357–63. https://www.rhesusbase.info/.
Vendrame TAP, Arnoni CP, Muniz JG, et al. Characterization of RHD alleles present in serologically RHD -negative donors determined by a sensitive microplate technique. Vox Sang 2019;8:869–75.
Hemker MB, Ligthart PC, Berger L, van Rhenen DJ, van der Schoot CE, Wijk PA. DAR, a new RhD variant involving exons 4, 5, and 7, often in linkage with ceAR, a new Rhce variant frequently found in African blacks. Blood 1999;94:4337–42.
von Zabern I, Wagner FF, Moulds JM, Moulds JJ, Flegel WA. D category IV: a group of clinically relevant and phylogenetically diverse partial D. Transfusion 2013;53:2960–73.

Auteurs

Carine P Arnoni (CP)

1Colsan-Associação Beneficente de Coleta de Sangue, São Paulo, SP, Brazil.

Tatiane A Vendrame (TA)

1Colsan-Associação Beneficente de Coleta de Sangue, São Paulo, SP, Brazil.

Flavia S Silva (FS)

1Colsan-Associação Beneficente de Coleta de Sangue, São Paulo, SP, Brazil.

Nayara M Silva (NM)

1Colsan-Associação Beneficente de Coleta de Sangue, São Paulo, SP, Brazil.

Afonso Cortez (A)

1Colsan-Associação Beneficente de Coleta de Sangue, São Paulo, SP, Brazil.

Flavia Latini (F)

1Colsan-Associação Beneficente de Coleta de Sangue, São Paulo, SP, Brazil.

Lilian Castilho (L)

2Hemocentro-Unicamp, Campinas, SP, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH